Trials
Search / Trial NCT05658224

Education Time Influence on Exercise-Induced Hypoalgesia

Launched by UNIVERSITY OF SOUTH DAKOTA · Dec 12, 2022

Apply for Trial

Trial Information

Current as of January 13, 2025

Completed

Keywords

Exercise Induced Hypoalgesia Education

ClinConnect Summary

The use of fliers will be posted on USD campus explaining study and the need for volunteers. Potential volunteers will contact study personal listed on the flier to set up potential time for study enrollment. When the prospective participant arrives, they will be provided a hard copy of informed consent and study personnel will be available to answer questions. If the participant consents and signs, they will then be screened to ensure inclusion/exclusion by answering screening questions.

Once they have consented and met study inclusion/exclusion the participants will then be randomized in...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • Able to read and understand English,
  • • Refrained from alcohol, pain medication, and vigorous exercise for the past 24 hours,
  • • No history of chronic pain (pain \> 3 months), or current pain/injury that would prevent the ability to do exercise.
  • Exclusion Criteria:
  • • unable to meet screening questions for PAR-Q+ for safe exercise

Trial Officials

Kory Zimney, DPT, PT

Principal Investigator

University of South Dakota

About University Of South Dakota

The University of South Dakota (USD) is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, USD leverages its diverse expertise in medicine, psychology, and health sciences to conduct rigorous clinical studies aimed at improving patient outcomes. The university's commitment to ethical research practices and community engagement ensures that its trials not only contribute to scientific knowledge but also address the health needs of the local and broader populations. Through its state-of-the-art facilities and a robust network of researchers and clinicians, USD is poised to make significant advancements in various therapeutic areas.

Locations

Vermillion, South Dakota, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials